Zeiss Announces 3 Million Eyes Treated With SMILE

Zeiss Medical Technology announced a new milestone with more than 3 million treated eyes with SMILE in more than 1,000 clinics worldwide.

SMILE, which became commercially available in the United States in 2017,  is a minimally-invasive corneal refractive procedure performed by using the VisuMaxfemtosecond laser to create a thin disc-shaped lenticule within the cornea, which is then removed through a small incision, thereby achieving the desired vision correction. SMILE requires only one laser to perform the entire solution leaving the outer corneal layer largely intact, thus potentially contributing to the cornea’s biomechanical and refractive stability after surgery.